• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.齐多夫定控释骨架片:制剂变量对体外药物释放动力学的影响
AAPS PharmSciTech. 2008;9(1):302-13. doi: 10.1208/s12249-007-9030-8. Epub 2008 Jan 25.
2
Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.采用羟丙基甲基纤维素制备齐多夫定口服控释片的设计与体外评价
Chem Pharm Bull (Tokyo). 2008 Apr;56(4):518-24. doi: 10.1248/cpb.56.518.
3
Design and study of lamivudine oral controlled release tablets.拉米夫定口服控释片的设计与研究
AAPS PharmSciTech. 2007 Dec 7;8(4):E101. doi: 10.1208/pt0804101.
4
Oral sustained release tablets of zidovudine using binary blends of natural and synthetic polymers.使用天然和合成聚合物的二元混合物的齐多夫定口服控释片。
Biol Pharm Bull. 2010;33(9):1561-7. doi: 10.1248/bpb.33.1561.
5
Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.使用优化技术开发塞来昔布口服控释制剂并进行体外评价。
Yakugaku Zasshi. 2006 Jul;126(7):505-14. doi: 10.1248/yakushi.126.505.
6
Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies.异烟肼控释亲水骨架片制剂:设计与体外研究
AAPS PharmSciTech. 2008;9(4):1171-8. doi: 10.1208/s12249-008-9159-0. Epub 2008 Nov 19.
7
Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.理解美国药典装置I和II对具有不同释放机制的片剂溶出动力学影响的机制方法。
AAPS PharmSciTech. 2017 Feb;18(2):462-472. doi: 10.1208/s12249-016-0535-x. Epub 2016 Apr 22.
8
Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.脂质和纤维素基质成型剂对挤出/球形化、烧结和压缩颗粒中高溶性药物释放的影响。
Lipids Health Dis. 2018 Jun 9;17(1):136. doi: 10.1186/s12944-018-0783-8.
9
The influence of the compression force on zidovudine release from matrix tablets.压缩力对齐多夫定从基质片剂中释放的影响。
AAPS PharmSciTech. 2010 Sep;11(3):1442-8. doi: 10.1208/s12249-010-9497-6. Epub 2010 Sep 15.
10
Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.利福平口服控释制剂。第二部分:制剂变量和工艺参数对体外释放的影响。
Drug Deliv. 2008 Mar-Apr;15(3):159-68. doi: 10.1080/10717540801952498.

引用本文的文献

1
Biodegradable polymeric solid implants for ultra-long-acting delivery of single or multiple antiretroviral drugs.可生物降解聚合物固体植入物,用于长效单一或多种抗逆转录病毒药物的递送。
Int J Pharm. 2021 Aug 10;605:120844. doi: 10.1016/j.ijpharm.2021.120844. Epub 2021 Jul 1.
2
Hydrogel-based matrices for controlled drug delivery of etamsylate: Prediction of plasma profiles.用于乙磺半胱氨酸控释给药的水凝胶基基质:血浆浓度曲线预测
Saudi Pharm J. 2020 Dec;28(12):1704-1718. doi: 10.1016/j.jsps.2020.10.016. Epub 2020 Nov 6.
3
Premium ethylcellulose polymer based architectures at work in drug delivery.基于高级乙基纤维素聚合物的结构在药物递送中的应用。
Int J Pharm X. 2019 Jul 8;1:100023. doi: 10.1016/j.ijpx.2019.100023. eCollection 2019 Dec.
4
Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives.基于不同纤维素衍生物的布洛芬片控释的神经模糊建模。
Drug Deliv Transl Res. 2019 Feb;9(1):162-177. doi: 10.1007/s13346-018-00592-0.
5
Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats.乳铁蛋白纳米颗粒在大鼠口服给药期间提高齐多夫定的安全性、生物利用度和药代动力学
PLoS One. 2015 Oct 13;10(10):e0140399. doi: 10.1371/journal.pone.0140399. eCollection 2015.
6
Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.基于Eudragit®E100/Carbopol®971P组合的基质片剂对水溶性模型药物扑热息痛控释及改善压缩性能的评价
AAPS PharmSciTech. 2015 Oct;16(5):1169-79. doi: 10.1208/s12249-015-0301-5. Epub 2015 Feb 28.
7
Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability.利培酮控释骨架片的研制:基于 Methocel®和 Ethocel®的新型聚合物共混物对体外药物释放和生物利用度的影响。
AAPS PharmSciTech. 2011 Jun;12(2):525-33. doi: 10.1208/s12249-011-9613-2. Epub 2011 Apr 15.
8
Guar gum, xanthan gum, and HPMC can define release mechanisms and sustain release of propranolol hydrochloride.瓜尔胶、黄原胶和 HPMC 可以控制盐酸普萘洛尔的释放机制和缓释。
AAPS PharmSciTech. 2011 Mar;12(1):77-87. doi: 10.1208/s12249-010-9570-1. Epub 2010 Dec 21.
9
Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels.设计并体外评价辣椒素透皮控释立方相凝胶。
AAPS PharmSciTech. 2010 Sep;11(3):1405-10. doi: 10.1208/s12249-010-9481-1. Epub 2010 Sep 14.
10
Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.奥氮平控释骨架片:聚合物对体外释放和生物利用度的影响。
AAPS PharmSciTech. 2010 Sep;11(3):1397-404. doi: 10.1208/s12249-010-9510-0. Epub 2010 Sep 8.

本文引用的文献

1
1. Commentary on an exponential model for the analysis of drug delivery: Original research article: a simple equation for description of solute release: I II. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs, 1987.1. 药物递送分析指数模型述评:原创研究文章:溶质释放描述的一个简单方程:I II. 平板、球体、圆柱体或圆盘形式的非溶胀装置中的菲克和非菲克释放,1987年。
J Control Release. 2014 Sep 28;190:31-2.
2
A common profile for polymer-based controlled releases and its logical interpretation to general release process.基于聚合物的控释常见概况及其对一般释放过程的逻辑解释。
J Pharm Pharm Sci. 2006;9(2):238-44.
3
Analysis of the release process of phenylpropanolamine hydrochloride from ethylcellulose matrix granules III. Effects of the dissolution condition on the release process.盐酸苯丙醇胺从乙基纤维素基质颗粒中的释放过程分析III. 溶解条件对释放过程的影响
Chem Pharm Bull (Tokyo). 2006 Aug;54(8):1091-6. doi: 10.1248/cpb.54.1091.
4
Formulation and in vitro, in vivo evaluation of extended- release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers.齐多夫定缓释骨架片的处方设计及体内外评价:亲水性和疏水性骨架材料组合的影响
AAPS PharmSciTech. 2006 Jan 3;7(1):E1. doi: 10.1208/pt070101.
5
Controlled release of saccharides from matrix tablets.糖类从骨架片的控释。
Eur J Pharm Biopharm. 2006 Feb;62(2):163-70. doi: 10.1016/j.ejpb.2005.07.009. Epub 2005 Dec 15.
6
Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets.制剂和工艺变量对阿莫西林基质片剂释放行为的影响。
Drug Dev Ind Pharm. 2004 Sep;30(8):901-8. doi: 10.1081/ddc-200034594.
7
An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers.基于新型卡波姆聚合物的亲水性基质片剂药物释放影响因素的研究。
Drug Deliv. 2004 Jan-Feb;11(1):59-65. doi: 10.1080/10717540490265379.
8
Swellable matrices for the controlled-release of diclofenac sodium: formulation and in vitro studies.用于双氯芬酸钠控释的可膨胀基质:制剂与体外研究
Pharm Dev Technol. 2004;9(1):75-83. doi: 10.1081/pdt-120027420.
9
Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance.HIV-1治疗期间的药物失效。监测耐药性的新视角。
New Microbiol. 2003 Oct;26(4):405-13.
10
Wet granulation fine particle ethylcellulose tablets: effect of production variables and mathematical modeling of drug release.湿法制粒乙基纤维素细颗粒片:生产变量的影响及药物释放的数学模型
AAPS PharmSci. 2003;5(2):E13. doi: 10.1208/ps050213.

齐多夫定控释骨架片:制剂变量对体外药物释放动力学的影响

Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics.

作者信息

Ravi Punna Rao, Kotreka Udaya Kanth, Saha Ranendra Narayan

机构信息

Pharmacy Group, Birla Institute of Technology and Science, Pilani, Rajasthan, India.

出版信息

AAPS PharmSciTech. 2008;9(1):302-13. doi: 10.1208/s12249-007-9030-8. Epub 2008 Jan 25.

DOI:10.1208/s12249-007-9030-8
PMID:18446496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2976876/
Abstract

The purpose of this research was to design oral controlled release (CR) matrix tablets of zidovudine (AZT) using hydroxypropyl methylcellulose (HPMC), ethyl cellulose (EC) and carbopol-971P (CP) and to study the effect of various formulation factors on in vitro drug release. Release studies were carried out using USP type 1 apparatus in 900 ml of dissolution media. Release kinetics were analyzed using zero-order, Higuchi's square root and Ritger-Peppas' empirical equations. Release rate decreased with increase in polymer proportion and compression force. The release rate was lesser in formulations prepared using CP (20%) as compared to HPMC (20%) as compared to EC (20%). No significant difference was observed in the effect of pH of dissolution media on drug release from formulations prepared using HPMC or EC, but significant difference was observed in CP based formulations. Decrease in agitation speed from 100 to 50 rpm decreased release rate from HPMC and CP formulations but no significant difference was observed in EC formulations. Mechanism of release was found to be dependent predominantly on diffusion of drug through the matrix than polymer relaxation incase of HPMC and EC formulations, while polymer relaxation had a dominating influence on drug release than diffusion incase of CP formulations. Designed CR tablets with pH independent drug release characteristics and an initial release of 17-25% in first hour and extending the release up to 16-20 h, can overcome the disadvantages associated with conventional tablets of AZT.

摘要

本研究的目的是使用羟丙基甲基纤维素(HPMC)、乙基纤维素(EC)和卡波姆-971P(CP)设计齐多夫定(AZT)的口服控释(CR)骨架片,并研究各种制剂因素对体外药物释放的影响。释放研究使用USP 1型装置在900 ml溶出介质中进行。使用零级、Higuchi平方根和Ritger-Peppas经验方程分析释放动力学。释放速率随聚合物比例和压力的增加而降低。与使用20% HPMC相比,使用20% CP制备的制剂释放速率较低,与使用20% EC相比也是如此。在使用HPMC或EC制备的制剂中,溶出介质的pH值对药物释放的影响未观察到显著差异,但在基于CP的制剂中观察到显著差异。搅拌速度从100 rpm降至50 rpm会降低HPMC和CP制剂的释放速率,但在EC制剂中未观察到显著差异。发现释放机制主要取决于药物通过骨架的扩散,而不是HPMC和EC制剂中聚合物的松弛,而在CP制剂中,聚合物松弛对药物释放的影响比扩散更大。设计的具有pH无关药物释放特性且在第一小时初始释放率为17 - 25%并将释放延长至16 - 20小时的CR片,可以克服与传统AZT片相关的缺点。